biomarker

Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying pathological…
Read More...

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around…
Read More...

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting over 8% of Americans, but…
Read More...

A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has…
Read More...

<!-- Name:DistributionId Value:8808254 --> <!--…
Read More...

An alpha-synuclein…
Read More...

<!-- Name:DistributionId Value:8793749 --> <!--…
Read More...

<!-- Name:DistributionId Value:8789256 --> <!--…
Read More...

<!-- Name:DistributionId Value:8788771 --> <!--…
Read More...

Investigators at the Brigham looked at 1,783 inpatients and outpatients who had cystatin C and creatinine levels drawn…
Read More...